Cytoprotective effect of taurine against hypochlorous acid toxicity to PC12 cells

Advances in Experimental Medicine and Biology

Volumn 483, Issue , 2000, Pages 563-570

  Kearns, Sean ^a   Dawson, Ralph ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BETA ALANINE; CYTOTOXIN; GLUTATHIONE; HYPOCHLOROUS ACID; ISETHIONIC ACID; NEUROPROTECTIVE AGENT; OXIDIZING AGENT; SCAVENGER; TAURINE;

ANIMAL; ARTICLE; CELL STRAIN; DOSE RESPONSE; RAT;

ANIMALS; ANTIOXIDANTS; BETA-ALANINE; CYTOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; GLUTATHIONE; HYPOCHLOROUS ACID; ISETHIONIC ACID; NEUROPROTECTIVE AGENTS; OXIDANTS; PC12 CELLS; RATS; TAURINE;

EID: 0034585491     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Weiss, S.J., Klein, R., Slivka, A. and Wei, M., 1982, Chlorination of taurine by human neutrophils: Evidence for hypochlorous acid generation. J. Clin. Invest. 70: 598-607.
2. Marquez, L.A. and Dunford, H.B., 1994, Chlorination of taurine by myeloperoxidase; kinetic evidence for an enzyme-bound intermediate. J. Biol. Chem. 269: 7950-7956.
3. Thomas, E.L., Grisham, M.B. and Jefferson, M.M., 1983, Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J. Clin. Invest. 72: 441-454.
4. Reynolds, W.F., Rhees, J., Macccciejewski, D., Paladino, T., Sieburg, H., Maki, R.A. and Masliah, E., 1999, Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exper. Neuro. 155: 31-41.
5. Smith, J.K., Grisham, M.B., Granger, D.N. and Korthuis, R.J., 1989, Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am. J. Physiol. 256: H7889-H793.
6. Raschke, P., Massoudy, P. and Becker, B.F., 1995, Taurine protects the heart from neutrophil-induced reperfusion injury. Free Rad. Biol. Med. 19: 461-471.
7. Hudome, S., Palmer, C., Roberts, R.L., Mauger, D., Housman, C. and Towfighi, J., 1997, The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat Pediatr Res 41: 607-616.
8. Jolivalt, C., Leninger-Muller, B., Drozdz, R., Naskalaski, J.W., and Siest, G., 1996, Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neurosci. Ltrs. 210: 61-64.
9. Schraufstatter, I.U., Browne, K., Harris, A., Hyslop, P.A., Jackson, J.H., Quehenberger, O. and Cochrane, C.G., 1990, Mechanisms of hypochlorite injury of target cells. J. Clin. Invest. 85: 554-562.
10. Prutz, W.A., 1996, Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch. Biochem. Biophys. 332: 110-120.
11. Folkes, L.K., Candeias, L.P., and Wardman, P., 1995, Kinetics and mechanisms of hypochlorous acid reactions. Arch. Biochem. Biophys. 323: 120-126.
12. Zgliczynski, J.M., Stelmaszynska, T., Domanski, J. and Ostrowski, W., 1971, Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase. Biochim. Biophys. Acta, 233: 419-424.
13. Cantin, A., 1994, Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. J. Clin. Invest. 93: 606-614.
14. Cunningham, C., Tipton, K.F., and Dixon, H.B.F., 1998, Conversion of taurine into N-chlorotaurine (taurine chloramine) and sulphoacetaldehyde in response to oxidative stress. J. Biochem. 330: 939-945.
15. Marcinkiewicz, J., Grabowska, A., Bereta, J. and Stelmaszynska, T., 1995, Taurine chloramine, a product of activated neutrophils, inhibits the generation of nitric oxide and other macrophage inflammatory mediators. J. Leukoc. Biol. 58: 667-674.
16. Liu, Y., Tonna-DeMasie, M., Park, E., Schuller-Levis, G. and Quinn, M.R., 1998, Taurine chloramine inhibits production of nitric oxide and prostaglandin E2 in activated C6 glioma cells by suppressing inducible nitric oxide synthase and cyclooxygenase-2 expression. Mol. Brain Res. 59: 189-195.
17. Redmond, H.P., Stapleton, P.P., Neary, P. and Boucher-Hayes, D., 1998, Immunonutrition: The role of taurine. Nutrittion 14: 599-604.
18. Green, T.R., Fellman, J.H., Eicher, A.L., and Pratt, K.L., 1991, Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils. Biochem. Biophys. Acta 1073: 91-97.
19. Huxtable, R.J., 1989, Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobio. 33: 471-533.
20. Seki, Y., Feustel, P.J., Keller, R. W., Trammer, B.I. and Kimelberg, H.K., 1999, Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke. 30: 43-440.
21. Saransaari, P. and Oja, S.S., 1997, Enhanced taurine release in cell damaging conditions in the developing and ageing mouse hippocampus. Neuroscience 79: 847-854.
22. Borowitz, J.L., Kanthasamy, A.G., Mitchell, P.J., and Isom, G.E., 1993, Use of PC12 cells as a neurotoxicological screen: characterization of anticyanide compounds. Fund. Appl. Toxicol. 20: 133-140.
23. Mosman, T., 1983, Rapid colormetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol Meth. 65: 55-63.
24. Kozumbo, W.J., Agarwal, S. and Koren, H.S., 1992, Breakage and binding of DNA by reaction products of hypochlorous acid with aniline, 1-naphthylamine, or 1-naphthol. Toxicol. Appl. Pharmacol. 115: 107-115.
25. Dawson, R., Liu, S., Eppler, B., and Patterson, T., 1999, Effects of dietary taurine supplementation or deprivation in aged male Fischer 344 rats. Mech. Aging Dev. 107: 73-91.
26. Finnegan, N.M., Redmond, H.P., and Bouchier-Hayes, D.J., 1998, Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury. Cancer 82: 186-199.